Company lists · Data refreshed September 2026

Top 20 Immunotherapy venture capital companies based in London, United Kingdom

RevenueBase identified 36 immunotherapy venture capital companies headquartered in London, United Kingdom as of September 2026 and tracks 1,218 professional contacts across them, including 785 with verified work emails and 153 with mobile numbers. London is the largest hub.

This list covers immunotherapy venture capital companies headquartered in London, United Kingdom, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 12, 2026.

Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.

How to read this list HQ checked on every row RevenueBase Smart Search rating on every row Refreshed Sep 12, 2026 86% judged on-target in blind review
36Companies
1,218Contacts tracked
785Verified emails
153Mobile numbers
Explore this list → Free signup · no credit card · 500 free credits

The 20 largest immunotherapy venture capital companies based in London, United Kingdom

Ranked by team size
Top 20 of 36 immunotherapy venture capital companies based in London, United Kingdom, ranked by team size, largest first. Data refreshed Sep 12, 2026. RevenueBase Smart Search rates how each company's information relates to immunotherapy venture capital companies: strong evidence (its own description names it), partial (names part of it), indirect (matched on the rest of its profile rather than the description shown). Click a contact count to view that company's people.
#CompanyRevenueBase Smart SearchHeadquartersEmployeesContacts
1Indirect evidenceLondon, United KingdomHQ checked Sep 12, 2026501-1,000712 contacts →

Indirect evidence

“Autolus is a CAR T cell therapy company.”

Source: RevenueBase Database · checked Sep 12, 2026
2Indirect evidenceLondon, United KingdomHQ checked Sep 12, 202651-200158 contacts →

Indirect evidence

“An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions.”

Source: RevenueBase Database · checked Sep 12, 2026
3Indirect evidenceLondon, United KingdomHQ checked Sep 12, 20261-1023 contacts →

Indirect evidence

“Centauri Therapeutics Limited is a UK-based biotechnology company focused on the discovery and development of novel molecules targeting life threatening diseases.”

Source: RevenueBase Database · checked Sep 12, 2026
4Indirect evidenceLondon, United KingdomHQ checked Sep 12, 202611-5022 contacts →

Indirect evidence

“Leucid is progressing novel CAR T therapies that produce a better and more durable response than previous CAR T generations, improving treatment outcomes and saving the lives of…”

Source: RevenueBase Database · checked Sep 12, 2026
5Partial evidenceLondon, United KingdomHQ checked Sep 12, 202611-5020 contacts →

Partial evidence

“LIFT BioSciences is pioneering a new class of immunotherapy for hard-to-treat cancers based on allogeneic Immuno-Modulatory Alpha Neutrophils (IMANs)®.”

Source: RevenueBase Database · checked Sep 12, 2026
6Partial evidenceLondon, United KingdomHQ checked Sep 12, 202611-5019 contacts →

Partial evidence

“Prokarium is pioneering the field of microbial immunotherapy.”

Source: RevenueBase Database · checked Sep 12, 2026
7Partial evidenceLondon, United KingdomHQ checked Sep 12, 202611-5019 contacts →

Partial evidence

“Broadening cancer patient access to powerful disease-transforming immunotherapy.”

Source: RevenueBase Database · checked Sep 12, 2026
8Strong evidenceLondon, United KingdomHQ checked Sep 12, 202611-5018 contacts →

Strong evidence

“4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.”

Source: RevenueBase Database · checked Sep 12, 2026
9Indirect evidenceLondon, United KingdomHQ checked Sep 12, 20261-1017 contacts →

Indirect evidence

“RQ Biotechnology is making instant immunity a reality for vulnerable people.”

Source: RevenueBase Database · checked Sep 12, 2026
10Partial evidenceLondon, United KingdomHQ checked Sep 12, 202611-5013 contacts →

Partial evidence

“Poolbeg Pharma plc (AIM: POLB) is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field.”

Source: RevenueBase Database · checked Sep 12, 2026
11Indirect evidenceLondon, United KingdomHQ checked Sep 12, 20261-1011 contacts →

Indirect evidence

“The 4C Biomed group is a biomed R&D start-up in the field of Immuno-Oncology operating in the UK through 4C Biomed Limited, supported in Israel through its wholly owned service…”

Source: RevenueBase Database · checked Sep 12, 2026
12Partial evidenceLondon, United KingdomHQ checked Sep 12, 202611-5011 contacts →

Partial evidence

“Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges…”

Source: RevenueBase Database · checked Sep 12, 2026
13Indirect evidenceLondon, United KingdomHQ checked Sep 12, 20261-1010 contacts →

Indirect evidence

“Duke Street Bio is focused on exploiting tumour genetic vulnerabilities and harnessing the natural power of the body’s immune system to fight cancer.”

Source: RevenueBase Database · checked Sep 12, 2026
14Indirect evidenceLondon, United KingdomHQ checked Sep 12, 20261-109 contacts →

Indirect evidence

“Celex is a leading biotechnology company focused on the research and development of cutting-edge cancer treatments.”

Source: RevenueBase Database · checked Sep 12, 2026
15Strong evidenceLondon, United KingdomHQ checked Sep 12, 20261-108 contacts →

Strong evidence

“ALSA Ventures is a life science venture capital investor, focused on early stage novel therapeutics.”

Source: RevenueBase Database · checked Sep 12, 2026
16Partial evidenceLondon, United KingdomHQ checked Sep 12, 202611-508 contacts →

Partial evidence

“NG Bio, an early-stage investor and venture builder addressing the harmful immune responses, such as inflammation, that cause or exacerbate many of the major human diseases.”

Source: RevenueBase Database · checked Sep 12, 2026
17Partial evidenceLondon, United KingdomHQ checked Sep 12, 20261-107 contacts →

Partial evidence

“VacV Biotherapeutics is a cancer immunotherapy company developing innovative viral-based therapies for cancers.”

Source: RevenueBase Database · checked Sep 12, 2026
18Indirect evidenceLondon, United KingdomHQ checked Sep 12, 20261-103 contacts →

Indirect evidence

“Roquefort Therapeutics is a LSE Main Market listed biotech company developing first in class drugs in the high value and high growth oncology segment prior to partnering or…”

Source: RevenueBase Database · checked Sep 12, 2026
19Indirect evidenceLondon, United KingdomHQ checked Sep 12, 202651-2002 contacts →

Indirect evidence

“GammaDelta Therapeutics is a UK headquartered biotechnology company founded upon world-class academic research conducted by Professor Adrian Hayday and Dr Oliver Nussbaumer, at…”

Source: RevenueBase Database · checked Sep 12, 2026
20Indirect evidenceLondon, United KingdomHQ checked Sep 12, 20261-102 contacts →

Indirect evidence

“Korecyte Bio is a cell therapy startup based in London, the United Kingdom and was established in 2023/2024.”

Source: RevenueBase Database · checked Sep 12, 2026

Showing 20 of 36 immunotherapy venture capital companies based in London, United Kingdom

See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 785 reachable decision-makers.

Free signup · no credit card

View the full list →

Immunotherapy venture capital companies based in London, United Kingdom at a glance

As of Sep 12, 2026
64.4%Verified-email coverage
12.6%Mobile-number coverage
33.8Average contacts per company
1-10Median size (employees)
102.8%Largest-city concentration · London
Sep 12, 2026Page data refreshed

Companies by employee count

1-10
18
11-50
15
51-200
2
501-1,000
1

Freshness & accuracy

How recently the business emails were verified and the company information checked

Email last verified

Median 15.0d

Company record updated

Median 58.5d

How this list was built

Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among immunotherapy venture capital companies, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.

Source
The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
What qualifies
Companies headquartered in London, United Kingdom whose own description of what they do matches “immunotherapy venture capital companies”. Matching reads each company's description, not its industry code or its name.
RevenueBase Smart Search
RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names immunotherapy venture capital companies), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
What we exclude
Companies whose own description does not clearly place them among immunotherapy venture capital companies, and records with no verified work email. Companies headquartered outside London are excluded even when they keep an office there.
Match quality
In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
Ranking
Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
Verification
Every listed company carries at least one verified work email, 785 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
Refresh
This page's figures were pulled from the company graph on September 12, 2026. Lists refresh periodically as the graph is re-checked.
Corrections
Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.

Immunotherapy venture capital companies by metro in the United Kingdom

  • Immunotherapy venture capital companies in London37

Frequently asked

What is RevenueBase Smart Search?

RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names immunotherapy venture capital companies, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.

How many immunotherapy venture capital companies are there based in London, United Kingdom?

RevenueBase identified 36 immunotherapy venture capital companies headquartered in London, United Kingdom as of September 2026, matched on each company's own description of what it does rather than its industry code.

What is the largest company on this list?

Autolus Therapeutics, headquartered in London, tops this list with the largest team on record.

Which city has the most immunotherapy venture capital companies?

London leads with 37 headquartered companies, followed by Oxford (13) and Cambridge (6).

How do I get contact information for these companies?

A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 785 verified decision-maker contacts tracked across these 36 companies.

How current is this list?

The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 12, 2026.

Ready to reach these companies? Verified emails and direct dials for all 36 immunotherapy venture capital companies based in London, United Kingdom. Start with a free account, no credit card.

Download this list →

Related lists

About this data

RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.